SCHEMBL7300800

SCHEMBL7300800

[c]1ccccc1Oc1ccc(-c2ccsc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.48
CYP2B6 P20813 3/20 0.48
CYP2E1 P05181 2/20 0.48
LTA4H P09960 3/20 0.39
KCNH2 Q12809 1/20 0.39
PTPRC P08575 1/20 0.36
TNK2 Q07912 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDGFRB P09619 3/20 0.33
PDGFRA P16234 3/20 0.33
LPL P06858 1/20 0.33
LIPG Q9Y5X9 1/20 0.33
HRH2 P25021 1/20 0.33
HRH1 P35367 1/20 0.33
PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9672822 0.83 GSTP1 (0.37) LTA4HCYP2C9CYP2C19
SCHEMBL6056745 0.79 CYP2A6 (0.65) CYP2A6CYP2B6CYP2E1LTA4HKCNH2
SCHEMBL7299247 0.76 LTA4H (0.41) CYP2A6CYP2B6CYP2E1LTA4HKCNH2
SCHEMBL7300809 0.76 CYP2A6 (0.45) CYP2A6CYP2B6CYP2E1LTA4HKCNH2
SCHEMBL8535180 0.75 LTA4H (0.52) LTA4H
SCHEMBL76698 0.74 LTA4H (0.50) LTA4H
Water SCHEMBL27530954 0.73 LTA4H (0.48) LTA4H
SCHEMBL28770243 0.73 LTA4H (0.48) LTA4H
SCHEMBL28263205 0.72 GSTP1 (0.36) LTA4HCYP2C9CYP2C19
SCHEMBL1220986 0.72 LTA4H (0.54) LTA4HCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP claimed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US claimed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP claimed
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed